RecruitingNCT02660645
Blue Light Cystoscopy With Cysview® Registry
Sponsor
Photocure
Enrollment
4,400 participants
Start Date
Apr 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Adult \>18 years old
- Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy
Exclusion Criteria3
- Porphyria
- Gross hematuria
- Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives
Interventions
DRUGHexaminolevulinate hydrochloride (HCL)
Instillation in bladder
DEVICEKarl Storz D-Light C Photodynamic Diagnostic (PDD) system
Cystoscopy procedure
Locations(23)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02660645
Related Trials
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT000268841 location
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
NCT0712999379 locations
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
NCT0697316127 locations
Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
NCT074754031 location
Bio Clinical Collection of Urothelial Carcinoma
NCT049704721 location